search
Back to results

Vitamin D Pilot Study in Patients With Multiple Sclerosis

Primary Purpose

Relapsing Remitting Multiple Sclerosis

Status
Completed
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
19 nor vitamin d
Sponsored by
University of Wisconsin, Madison
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Relapsing Remitting Multiple Sclerosis focused on measuring Vitamin D, 19 nor Vitamin D, Multiple Sclerosis

Eligibility Criteria

18 Years - 45 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • relapsing remitting MS

Exclusion Criteria:

  • MRI contraindicated

Sites / Locations

  • UW-Madison

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

19 nor vitamin d

Arm Description

Outcomes

Primary Outcome Measures

MRI Measure of new active lesions, observation vs. treatment

Secondary Outcome Measures

Full Information

First Posted
December 8, 2010
Last Updated
October 1, 2015
Sponsor
University of Wisconsin, Madison
search

1. Study Identification

Unique Protocol Identification Number
NCT01257958
Brief Title
Vitamin D Pilot Study in Patients With Multiple Sclerosis
Official Title
Vitamin D Pilot Study in Patients With Multiple Sclerosis
Study Type
Interventional

2. Study Status

Record Verification Date
December 2010
Overall Recruitment Status
Completed
Study Start Date
February 1998 (undefined)
Primary Completion Date
February 2000 (Actual)
Study Completion Date
June 2000 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Wisconsin, Madison

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Phase 1 study of 19-nor Vitamin D in relapsing-remitting MS. Primary measure is MRI.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Relapsing Remitting Multiple Sclerosis
Keywords
Vitamin D, 19 nor Vitamin D, Multiple Sclerosis

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1
Interventional Study Model
Single Group Assignment
Allocation
N/A

8. Arms, Groups, and Interventions

Arm Title
19 nor vitamin d
Arm Type
Experimental
Intervention Type
Drug
Intervention Name(s)
19 nor vitamin d
Primary Outcome Measure Information:
Title
MRI Measure of new active lesions, observation vs. treatment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: relapsing remitting MS Exclusion Criteria: MRI contraindicated
Facility Information:
Facility Name
UW-Madison
City
Madison
State/Province
Wisconsin
ZIP/Postal Code
53792
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Vitamin D Pilot Study in Patients With Multiple Sclerosis

We'll reach out to this number within 24 hrs